Skip to content

Clinical trials

Diabetic Retinopathy trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Retinopathy Country / region: Germany Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20063
20081
20122
20132
20142
20152
20171
20181
20191
20202
20211
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated4
Recruiting2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
Novartis Pharmaceuticals2
Oxurion2
Quark Pharmaceuticals2
ThromboGenics2
University Hospital Tuebingen2
BCN Peptides1
Boehringer Ingelheim1
Chromaderm, Inc.1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Retinopathy22
Diabetes Mellitus8
Macular Edema6
Vision Disorders3
Retinal Diseases2
Retinal Vein Occlusion2
Anemia1
Choroidal Neovascularization1
Diabetes Complications1
Diabetic Foot1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.